| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.167.3.246 |
| P698 | PubMed publication ID | 17296879 |
| P50 | author | Bruce M. Psaty | Q30429993 |
| David S Siscovick | Q86839898 | ||
| Susan R Heckbert | Q88077554 | ||
| Lisa A Jackson | Q97556689 | ||
| P2093 | author name string | Nicholas L Smith | |
| Nicole L Glazer | |||
| Sascha Dublin | |||
| Benjamin French | |||
| Jennifer B Hrachovec | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 246-52 | |
| P577 | publication date | 2007-02-12 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Newly detected atrial fibrillation and compliance with antithrombotic guidelines | |
| P478 | volume | 167 |
| Q27341873 | 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society |
| Q35089113 | A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol. |
| Q33949244 | A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks |
| Q27026830 | A systematic review of validated methods for identifying atrial fibrillation using administrative data |
| Q36179688 | Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol. |
| Q38043562 | Anticoagulation bridging around device surgery: compliance with guidelines |
| Q27010464 | Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? |
| Q47911720 | Are Older Adults Willing to Consider New Strategies to Reduce Stroke Risk? |
| Q33829782 | Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data |
| Q28709414 | Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation |
| Q39932702 | Atrial fibrillation and ethnicity: the known, the unknown and the paradox |
| Q30505985 | Atrial fibrillation and risk of dementia: a prospective cohort study |
| Q36620437 | Beneficial effects of stroke-unit care in stroke patients with atrial fibrillation. |
| Q48066338 | Choice of Health Options In prevention of Cardiovascular Events for people with Atrial Fibrillation (CHOICE-AF): A pilot study |
| Q37743508 | Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation |
| Q37115353 | Dabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy? |
| Q37870757 | Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation |
| Q42432752 | Decoding cryptogenic cardioembolism |
| Q47642306 | Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. |
| Q35966775 | Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation |
| Q36657968 | Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation. |
| Q90749010 | Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial |
| Q44442004 | Emergency Department Utilization by Children in the USA, 2010-2011. |
| Q59138514 | Emergency department visits for paroxysmal supraventricular tachycardia in Saudi Arabia |
| Q33714864 | Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillation |
| Q37581151 | Five years of keeping a watch on the left atrial appendage-how has the WATCHMAN fared? |
| Q36981702 | Heart failure performance measures: eligibility and implementation in the community |
| Q47098511 | Impact of electronic clinical decision support on adherence to guideline-recommended treatment for hyperlipidaemia, atrial fibrillation and heart failure: protocol for a cluster randomised trial. |
| Q30371014 | Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. |
| Q37680357 | Inappropriate combination of warfarin and aspirin |
| Q37288459 | Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study |
| Q34232375 | Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis |
| Q36185363 | Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation: Results from the Health, Aging, and Body Composition Study |
| Q34448321 | Long-term outcomes following development of new-onset atrial fibrillation during sepsis |
| Q38303442 | Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation |
| Q35639707 | Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care |
| Q35966802 | Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry |
| Q37631671 | Paroxysmal supraventricular tachycardia and the risk of ischemic stroke |
| Q47355542 | Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). |
| Q90349962 | Posttraumatic Stress Disorder and Risk for Early Incident Atrial Fibrillation: A Prospective Cohort Study of 1.1 Million Young Adults |
| Q55222788 | Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa. |
| Q98161822 | Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge |
| Q34150474 | Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis |
| Q51335375 | Proportion of patients with implanted permanent pacemakers with atrial fibrillation receiving appropriate medical prophylaxis in North Wales. |
| Q27311041 | Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. |
| Q90124153 | Racial Differences in Hospital Death for Atrial Fibrillation: The National Inpatient Sample 2001-2012 |
| Q64236943 | Risk factors for medication non-adherence among atrial fibrillation patients |
| Q38732470 | Risk of incident atrial fibrillation in gout: a cohort study. |
| Q92615799 | Sensitivity, specificity, positive and negative predictive values of identifying atrial fibrillation using administrative data: a systematic review and meta-analysis |
| Q41997375 | Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial |
| Q89352762 | Sleep characteristics that predict atrial fibrillation |
| Q53803663 | Stroke Prevention in Atrial Fibrillation. |
| Q45159932 | The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation |
| Q44872562 | The case-crossover study design in pharmacoepidemiology. |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q50181100 | The significance of atrial fibrillation in patients aged ≥ 55 years undergoing abdominal surgery |
| Q37030961 | The use of anticoagulants in the management of atrial fibrillation among general practices in England |
| Q37959031 | Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. |
| Q28081837 | Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options |
| Q39659827 | Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice |
| Q91576314 | Validation of an algorithm based on administrative data to detect new onset of atrial fibrillation after cardiac surgery |
| Q41657202 | Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation |
Search more.